About

Darbepoetin alfa is a modified recombinant human erythropoietin with a longer half-life than epoetin alfa, allowing for less frequent dosing. It stimulates erythropoiesis by binding to erythropoietin receptors on erythroid progenitor cells in the bone marrow, promoting their proliferation and differentiation into mature red blood cells. This action leads to an increase in hemoglobin levels and red blood cell mass. Darbepoetin alfa is primarily used to treat anemia associated with chronic kidney disease and chemotherapy-induced anemia in cancer patients, effectively reducing the need for red blood cell transfusions and improving patient quality of life. Its extended duration of action offers convenience and sustained therapeutic effect.

Uses

Treatment of anemia in chronic kidney disease.
Anemia in cancer patients receiving chemotherapy.
Prevention of anemia in certain surgical settings.
Management of anemia in myelodysplastic syndromes.

Directions For Use

Administer subcutaneously or intravenously, typically once weekly or every two weeks, as prescribed by a physician.

Benefits

Increases red blood cell count and hemoglobin.
Reduces the need for blood transfusions.
Less frequent dosing due to longer half-life.
Alleviates symptoms of anemia like fatigue.
Improves quality of life for anemic patients.
Supports recovery from chemotherapy.

Side Effects

Hypertension
Headache
Fever
Nausea
Vomiting
Diarrhea
Injection site pain
Thromboembolic events
Seizures
Allergic reactions
Pure red cell aplasia (rare)
Rash

Safety Measures

Alcohol - No direct interaction; however, excessive alcohol can worsen anemia or liver function.
Pregnancy - Use only if clearly needed; consult a doctor as data on human pregnancy is limited.
Breastfeeding - Excreted in breast milk; use with caution and medical advice.
Liver - Use with caution in patients with severe liver impairment; monitor closely.
Kidney - Commonly used in chronic kidney disease; monitor blood pressure and hemoglobin closely.
Lung - Generally safe; no specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location